Pharmacology · 2008 · 23 citations · 0 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPulmonologyRespiratory PharmacotherapyBronchodilator TherapyChronic Obstructive Pulmonary Disease PharmacotherapyObstructive Lung DiseaseRespiratory MedicineRespiratory PharmacologyAdverse Effects Of BronchodilatorsArterial Blood Gas AssessmentArterial Blood Pressure MeasurementBeta-adrenergic AgentsBeta2-adrenergic Agonist TherapyBronchodilator Dose-responseBronchodilator EfficacyRespiratory Drug Therapy
A double-blind crossover comparison was made of the effect of orally administered terbutaline (a new adrenergic drug with major action on beta2-receptors), ephedrine, and placebo in 15 patients with obstructive airways disease. Serial determination of ventilatory tests, arterial gas tensions, arterial blood pressure, ECG, blood chemistries, and urinalysis were made before and after administration of the tested drug. Terbutaline (5 mg) was found to be an effective bronchodilator with minimal side effects and an earlier onset and longer duration of action than ephedrine (25 mg).